Pharmacopsychiatry, 0176-3679

Journal

  1. 2019
  2. 2018
  3. 2016
  4. 2014
  5. 2013
  6. 2011
  7. 2009
  8. Novick, D., Gonzalez-Pinto, A., Haro, J. M., Bertsch, J., Reed, C., Perrin, E., ... EMBLEM Advisory Board (2009). Translation of Randomised Controlled Trial Findings into Clinical Practice: Comparison of Olanzapine and Valproate in the EMBLEM Study. Pharmacopsychiatry, 42(4), 145-152. https://doi.org/10.1055/s-0028-1128115
  9. 2008
  10. 2005
  11. Mookhoek, E. J., Meijs, V. M. M., Loonen, A. J. M., & Leufkens, H. G. M. (2005). Dyspepsia in chronic psychiatric patients. Pharmacopsychiatry, 38(3), 125-127. https://doi.org/10.1055/s-2005-864123
  12. Hugenholtz, GWK., Heerdink, ER., Meijer, WE., Stolker, JJ., Egberts, ACG., & Nolen, WA. (2005). Reasons for switching between antipsychotics in daily clinical practice. Pharmacopsychiatry, 38(3), 122-124. https://doi.org/10.1055/s-2005-864122
  13. 2004
  14. Klumpers, U. M. H., Boom, K., Janssen, F. M. G., Tulen, J. H. M., & Loonen, A. J. M. (2004). Cardiovascular risk factors in outpatients with bipolar disorder. Pharmacopsychiatry, 37(5), 211-216. https://doi.org/10.1055/s-2004-832594
  15. 2003
  16. Rijcken, C. A. W., Boelema, G. J., Slooff, C. J., Beuger, P. J., Tanja, T. A., & de Jong-van den Berg, L. T. W. (2003). Off-label use of antipsychotics in the community pharmacy: The sex differences. Pharmacopsychiatry, 36(5), 187-191.
  17. 1996
  18. 1992
  19. Nijdam, J. R., Doorschot, C. H., Van Bavel, L. P., & Loonen, A. J. M. (1992). A comparison of carbamazepine Divitabs and a normal carbamazepine preparation in psychiatric and oligophrenic patients. Pharmacopsychiatry, 25(3), 145-149.

ID: 17491470